Eye Care News: Recent News in Eye care
Eye care News Feed
- Sandoz received FDA approval for its biosimilar Enzeevu (aflibercept-abzv) on August 12, 2024. It has the same dosage form, route of administration, and presentation as the reference medicine, Eylea, from Regeneron.
- This update from UHC includes procedures enabled with its OMNI Surgical System technology from Sight Sciences.
- In both trials, Beacon’s lead program, laru-zova, was found to be well-tolerated by SKYLINE participants through month 36 and DAWN patients at month 9 or longer.
- Roche reveals promising results for Vabysmo in treating eye diseases, showcasing significant vision improvements and safety in recent clinical trials.
- OCT-A angiography can help reveal early neurodegenerative disease signs, offering a non-invasive method for identifying high-risk patients through retinal analysis.
- Opus Genetics doses first patient in LYNX-3, phase 3 trial of phentolamine ophthalmic solution 0.75%Phentolamine ophthalmic solution 0.75% is for the treatment of significant, chronic night driving impairment in keratorefractive patients with reduced mesopic vision.
- The start of the series that asks leading experts in the field what eye disease they would cure and why.
- A study reveals Hispanic patients face lower success rates in trabeculectomy with MMC compared to European patients, highlighting significant disparities in glaucoma surgery outcomes.
- Dr. Tanna will kick off the new monthly subspecialty education series with a virtual session on September 9, 2025, focused on using OCT imaging and perimetry to track glaucoma progression.
- The acquisition includes the noninvasive Valeda PBM device for the treatment of early and intermediate dry age-related macular degeneration.
- Course director Robert S. Feder, MD, shares how the monthly Zoom sessions aim to deliver clinical pearls and foster cross-subspecialty learning.
- Ashvattha Therapeutics reveals phase 2 results for migaldendranib, showing significant vision improvements and reduced injection needs in retinal disease patients.
- Roche's Contivue platform gains EU CE mark, offering innovative treatment for neovascular AMD with fewer injections and promising long-term vision outcomes.
- OpZira Inc. launches innovative ophthalmic diagnostic tools, enhancing early detection and monitoring of ocular diseases for improved patient outcomes.
- VirtuaLens revolutionizes cataract care with its VR IOL Simulator, empowering patients to make informed lens choices through immersive experiences.
- This marks the first time that the TearCare System has been included in the TFOS DEWS III Management and Therapy Report.
- A study reveals similar risks of sight-threatening diabetic retinopathy in pregnant women with type 1 diabetes compared to nonpregnant controls.
- Outlook Therapeutics seeks FDA clarity on ONS-5010 after a complete response letter, aiming to address efficacy concerns for wet AMD treatment.
- Neurolens, the innovation company redefining eye care through exceptional patient outcomes, is proud to announce its official rebrand to Newton. Named after Sir Isaac Newton—a great innovator who laid the […] This story Neurolens Rebrands as Newton – appears on The Optical Journal.
- Woodys has launched Unique Bakery, a campaign that celebrates Unique People in a setting as original as they are: a coffee shop where the unexpected is the norm. Here, playing […] This story Woodys Unique Bakery 2025 – appears on The Optical Journal.
- John Seegers of OpticianWorks and Laramy-K have graciously shared some of their awesome videos with us to share with you. John is one of the best trainers of opticians, and his video […] This story Teachable Tuesday – Optician Hand Tools – Screwdriver – appears on The Optical Journal.
- Erker’s 1879 will debut the Gold Medal Collection at Vision Expo West – a line of eyewear that pays tribute to the Olympic heritage of the Erker family. The collection […] This story Erkers 1879 Gold Medal Collection – appears on The Optical Journal.
- Take a deep breath, roll the dice, and watch – every throw is a winner with this new WOOW collection! The French brand is more confident than ever in asserting its […] This story WOOW – Let’s Play – appears on The Optical Journal.
- At SILMO Paris 2025, the spotlight is on the future of optics with the launch of the Tech Village, a brand-new space entirely dedicated to artificial intelligence and smart eyewear. […] This story Smart Eyewear & AI Take Center Stage At SILMO Paris 2025 – appears on The Optical Journal.
- VSP Vision™ announced today it has entered into a definitive agreement to acquire Marcolin from PAI Partners, a pre-eminent private equity firm, and other minority shareholders. The acquisition of Marcolin, […] This story VSP Vision Enters into Definitive Agreement to Acquire Marcolin – appears on The Optical Journal.
- In order to assist visitors and exhibitors attending MIDO 2026 (January 31, February 1-2) from the United States, Canada, Central and South America, special discounts on flight rates in economy, […] This story Special Travel Deals For MIDO 2026 – appears on The Optical Journal.
- This season, Evatik debuts a refined selection of seven new styles designed with the modern man in mind. From bold acetate frames to sleek stainless steel and combination designs, the […] This story Evatik – Elevated Eyewear For The Modern Man – appears on The Optical Journal.
- For its 30th anniversary, FACE A FACE teams up with designer Valentin Lebigot to unveil a unique installation at the DEGree flagship store, for the Paris Design Week, from September […] This story DEGree Celebrates FACE A FACE 30th Anniversary – appears on The Optical Journal.
- Xiidra is a prescription eye drop used to treat the signs and symptoms of dry eye disease (DED) and works by targeting the source of inflammation.
- The trial will evaluate the solution in treating significant, chronic night driving impairment in keratorefractive patients with reduced mesopic vision.
- The lens portfolio includes spherical, aspheric, toric, multifocal, multifocal toric, reverse geometry, and keratoconic contact lenses.
- Catch up on the top stories in optometry during the week of September 1-September 5.
- Dan Ignaszewski, executive director of the Alliance for Eye and Vision Research and the National Alliance for Eye and Vision Research, provides insight into the new campaign and how to get involved.
- Findings from the retrospective, observational study support the potential anti-inflammatory benefits of the drug class.
- Panelists discuss how to perform corneal sensitivity testing using methods ranging from cotton swabs to the more quantitative Brill esthesiometer, emphasizing that testing should become routine practice.
- Panelists discuss how to differentiate neurotrophic keratitis (NK) from dry eye disease and blepharitis by focusing on patient history, chief complaints, and the critical importance of corneal sensitivity testing.
- Calista Ming, OD, FAAO, FSLS, provides 3 cases of how to fit specialty lenses at the right time for patients.
- Outlook Therapeutics seeks FDA clarity on ONS-5010 after a complete response letter, aiming to address efficacy concerns for wet AMD treatment.
- The optometric giant recently passed away at the age of 97.
- The company stated that the distinguishing feature of the new Ahmed ClearPath ST is its smaller tube lumen.
- Naureen Haroon, OD, MPH, FAAO, founder of the newly formed WHSIG, said the group's primary aim is to educate the optometric community about why certain eye conditions disproportionately affect women.
- Keeping up with dry eye: Approaches to treatment plans, patient education, and clinical developmentsDry eye specialists weigh in on what role dry eye plays in their practices.
- The research, published in JAMA Health Forum, examined 950 AIMDs approved by the US Food and Drug Administration as of November 2024.
Follow us in Facebook
You must be logged in to post a comment.